Search results
Results from the WOW.Com Content Network
The overall 5-year survival rate of lobular carcinoma in situ has been estimated to be 97%. [16] LCIS (lobular neoplasia is considered pre-cancerous) is an indicator (marker) identifying women with an increased risk of developing invasive breast cancer. This risk extends more than 20 years.
The term carcinoma in situ may be used interchangeably with high-grade SIL. [8] Ductal carcinoma in situ of the breast is the most common precancer in women. Bowen's disease is a squamous carcinoma in situ of the skin. Colon polyps often contain areas of CIS that will almost always transform into colon cancer if left untreated.
Colorectal cancer (CRC), also known as bowel cancer, colon cancer, or rectal cancer, is the development of cancer from the colon or rectum (parts of the large intestine). [5] Signs and symptoms may include blood in the stool , a change in bowel movements , weight loss, abdominal pain and fatigue. [ 9 ]
A precancerous condition is a condition, tumor or lesion involving abnormal cells which are associated with an increased risk of developing into cancer. [1] [2] [3] Clinically, precancerous conditions encompass a variety of abnormal tissues with an increased risk of developing into cancer.
Lobular carcinoma is a form of tumor which primarily affects the lobules of a gland. It is sometimes considered equivalent to "terminal duct carcinoma". [1] If not otherwise specified, it generally refers to breast cancer. Examples include: Lobular carcinoma in situ; Invasive lobular carcinoma
Invasive lobular carcinoma Index of articles associated with the same name This set index article includes a list of related items that share the same name (or similar names).
Carcinomas of mixed type will have a specialized pattern or lobular carcinoma in the majority (i.e. at least 50%) of the tumor and a non-specialized pattern in between 10 and 49% of the sample. Thus, such tumors will be called mixed invasive NST and special type or mixed invasive carcinoma NST and lobular carcinoma. [24]
M8522/2 Intraductal carcinoma and lobular carcinoma in situ (C50._) M8522/3 Infiltrating duct and lobular carcinoma (C50._) Lobular and ductal carcinoma; Infiltrating duct and lobular carcinoma in situ; Intraductal and lobular carcinoma; Infiltrating lobular carcinoma and ductal carcinoma in situ; M8523/3 Infiltrating duct mixed with other ...